Phenyl / pyridyl-n-phenyl / pyridyl derivatives for treating a RNA virus infection
PT3820850TActive Publication Date: 2026-06-18INSTITUT CURIE +3
0 Cites 0 Cited by
Patent Information
- Application Number
- PT2019742313T
- Authority / Receiving Office
- PT · PT
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-07-09
- Filing Date
- 2019-07-09
- Publication Date
- 2026-06-18
- Estimated Expiration
- 2039-07-09
AI Technical Summary
Technical Problem
There are few effective treatments for RNA virus infections, particularly those caused by Group IV and V viruses of the Baltimore classification, with existing therapies mainly focused on symptom relief rather than cure.
Method used
Development of aryl-N-aryl compounds with broad-spectrum activity against single-stranded RNA viruses, specifically targeting Group IV and V viruses, including Chikungunya, Dengue, and Influenza viruses, through chemical synthesis.
Benefits of technology
The compounds demonstrate efficacy in preventing and treating RNA virus infections by inhibiting viral replication and reducing symptom severity.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.